Claris
   Select Language : myClaris
Claris Lifesciences Limited - India

  Career                :   Contact Us
India's Best Companies to Work for 2010


 

The company's commitment to research is manifested through the R&D team. The team's focus is in the area of development of innovative New Drug Delivery Systems (NDDS) for the management of critical illnesses. R&D team has pioneered a number of technologies in the last few years.
The company used R&D team's expertise in the area of Parenteral Fat Emulsions (Lipid Drug Delivery Systems) to manufacture Propofol.
R&D team has developed expertise in Liposomal Drug Delivery Systems. There are several drugs in the pipeline, which have reached a threshold for the next stage in development.




 

Development of products like TNA/TNA-Peri/PNA (triple /double chamber nutrition system), Glutammune (l-glutamine), TetraHES (tetrastarch), Sufentil (sufentanil citrate Inj.) are significant breakthroughs for R&D team.
A proprietary multi-layer film has been developed for bag manufacturing.
Specific bulk drugs development (API) like Hydroxyethyl starch, Iron sucrose, makes Claris one of the few manufacturers of such APIs in the world.
R&D team of qualified scientists with background in pharmaceutical sciences and allied areas, networks with the global scientific community including companies, universities and scientists with similar interest areas.
Useful Links   Products   Manufacturing   Capabilities   Investors   Media
Home
About Us
Partner Us
Career
Contact Us
Anesthesia
Nutrition
Plasma Volume
Expanders

Blood Product
Anti-Infectives
Renal & Transplant
Oncology
Infusion Therapy
Select Injectables
Emotional
Pharmacopoeia

Facilities
Regulatory
Delivery Systems
R&D / F&D
Investors
Investor FAQs
Corporate
Governance

Board of Directors'
Profile

Key Management
Personnel

Statutory Compliance
Photo Gallery
Investor Contact

Press Room
Press Kit
Media Contact
 
Claris Lifesciences Ltd. All Rights Reserved.  :: Terms of Use  :: Privacy Policy :: Sitemap